Description

Early Protein O, Pseudorabies Virus CAS NO 143891-25-2 is a critical viral protein component used in advanced virology research and vaccine development. This compound is essential for studying the pathogenesis and immunology of the Pseudorabies Virus (PRV), a significant pathogen in veterinary medicine. It serves as a key reagent for researchers and manufacturers in the biotechnology, veterinary pharmaceutical, and diagnostic industries, enabling the creation of effective vaccines and sensitive diagnostic assays.

Application

• Veterinary Vaccine Development: A key antigen for the research and production of subunit or inactivated vaccines against Pseudorabies (Aujeszky's disease) in swine.
• Immunoassay Reagent: Used as a coating antigen or standard in diagnostic test kits, such as ELISA, for the detection of PRV-specific antibodies.
• Virology Research: Fundamental tool for studying PRV protein function, virus-host interactions, and viral replication mechanisms.
• Antibody Production: Serves as an immunogen for generating monoclonal or polyclonal antibodies in laboratory animals for research and diagnostic purposes.
• Quality Control Reference: Acts as a reference standard in the quality control of PRV vaccines and related biological products.
• Academic & Institutional Research: Supports basic and applied research in universities, government labs, and animal health institutes.

Basic Information

Product Name	Early Protein O, Pseudorabies Virus
CAS No.	143891-25-2
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	PRV Early Protein O; Pseudorabies Virus Protein O; Aujeszky's Disease Virus Early Protein O; PRV EP-O; Glycoprotein O (gO) of Suid herpesvirus 1; SHV-1 Early Protein O; Viral Envelope Glycoprotein O
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is characterized for identity, purity, and biological activity using advanced analytical techniques. Certificates of Analysis (COA) detailing specific results for purity, endotoxin levels, and sterility (where applicable) are available upon request. Production follows strict quality management protocols suitable for research and in-vitro diagnostic use.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. This material is hygroscopic (moisture-sensitive); allow the vial to equilibrate to room temperature in a desiccator before opening to prevent condensation. For short-term use, store at 2-8°C. Avoid repeated freeze-thaw cycles.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder
Identification (SDS-PAGE/Western Blot)	Conforms
Purity (SDS-PAGE)	≥ 90%
Protein Content (BCA/Bradford)	≥ 1.0 mg/vial
Endotoxin Level (LAL)	< 1.0 EU/mg
Biological Activity (ELISA Binding)	Conforms
Solubility	Soluble in PBS or suitable aqueous buffer

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.